Antibodies directed against prothrombin fragment f1+2, the...

Details Antibodies directed against prothrombin fragment f1+2, the... Antibodies directed against prothrombin fragment f1+2, the...

C - Chemistry, Metallurgy

12

N

C12N 9/74 (2006.01) A61K 38/04 (2006.01) A61K 38/48 (2006.01) C07K 7/04 (2006.01) C07K 16/40 (2006.01) C12N 5/12 (2006.01) C12N 5/16 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2488127

The invention relates to antibodies directed against F1+2, to the preparation and use thereof, especially in therapy and diagnosis. The antibodies bind to an epitope on the N-terminal half of the F2 fragment of prothrombin.

Affiliated with

Also associated with

Rating

Antibodies directed against prothrombin fragment f1+2, the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies directed against prothrombin fragment f1+2, the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies directed against prothrombin fragment f1+2, the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2008469